|
Feb 10
|
Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats
|
|
Feb 10
|
NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes
|
|
Feb 10
|
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises
|
|
Jan 4
|
Declining Stock and Solid Fundamentals: Is The Market Wrong About ResMed Inc. (NYSE:RMD)?
|
|
Jan 3
|
Top Stock Reports for UnitedHealth, Costco & IBM
|
|
Jan 3
|
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business
|
|
Jan 3
|
3 GARP Stocks That Investors Can Scoop Up for Maximum Returns
|
|
Jan 3
|
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
|
|
Jan 3
|
ResMed Gains 37.8% in a Year: What's Driving the Stock?
|
|
Jan 3
|
Reasons to Retain Phibro Stock in Your Portfolio Now
|
|
Jan 3
|
Reasons to Retain Medtronic Stock in Your Portfolio Now
|
|
Jan 2
|
McKesson Stock Declines Post Divestiture of Canada-Based Businesses
|
|
Jan 2
|
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
|
|
Dec 31
|
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
|
|
Dec 31
|
Here's Why You Should Hold IART Stock in Your Portfolio Now
|
|
Dec 30
|
Here's Why ResMed (RMD) is a Strong Value Stock
|
|
Dec 30
|
Reasons to Retain AMED Stock in Your Portfolio Now
|
|
Dec 30
|
Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 56% gain
|
|
Oct 3
|
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
|
|
Oct 3
|
Zacks.com featured highlights Ferrari, Vertex, ResMed and Hubbel
|